Computed Tomography

Cardiac computed tomography (CT) has become a primary cardiovascular imaging modality in the past 20 years, and was recommended as a 1A recommendation in the 2021 chest pain assessment guidelines. CT calcium scoring has became a primary risk assessment for coronary artery disease and whether patients should be on statins. Coronary CT angiography (CCTA) is used to for anatomical assessment of the arteries for plaque burden and to identify areas of blockage that may cause ischemia and heart attacks. Additional use of contrast CT perfusion or fractional flow reserve CT (FFR-CT) can offer physiological information on the function of the heart. CT plays a primary role in structural heart assessments for heart valves, repair of congenital defects and left atrial appendage occlusion (LAAO) for both pre-procedure planning and procedural guidance. Find more news on general radiology CT use.

Cardiologist Carlos Collet takes new leadership role with CRF
Collet, known globally for his dedication to innovation, is the organization's new director of cardiovascular imaging, physiology and translational therapeutics.
FDA clears GE Revolution Vibe CT scanner aimed at rapidly growing CCTA market
“FDA clearance comes at the perfect time, with guidelines being adopted clinically for cardiac CT and with positive reimbursement driving procedure growth," says Jean-Luc Procaccini, CEO, molecular imaging and CT.
How to address CCTA staffing shortages
Jaime Warren, EdD, FACC, vice president of care transformation at MedAxiom, an ACC company, explains what is needed to address staffing shortages created by a 94% increase in cardiac CT volumes over the past 5 years.
Nuclear imaging company Positron moves to New York for ‘exciting new chapter’
Positron made the move to help its case when it files an official Form 10 registration statement with the SEC.
FDA clears CCTA AI coronary plaque assessment from Artrya
Australia-based Artrya Limited says its AI-enabled Salix Coronary Plaque module offers near real-time, point-of-care CCTA assessment and management of coronary artery disease.

Imaging group says new guidelines for chest pain contain some ‘troubling recommendations’

The update is meant to help clinicians improve outcomes while reducing costs, but one advocate says certain imaging suggestions may cause unanticipated harm.

‘A watershed moment’: HeartFlow praises new chest pain guidelines

The company showed its support for the guidelines in a new statement.

Radiologists should watch for these 3 pulmonary findings linked to increased COVID mortality

Experts looked beyond common pulmonary consolidations, finding a handful of accurate indicators of in-hospital mortality.

CAD-RADS a ‘big step in the right direction’ toward improving outcomes for acute chest pain

Korean researchers tested the Coronary Artery Disease Reporting and Data System in nearly 1,500 patients treated across four hospital emergency departments.

Chest CT, perfusion imaging spots pulmonary embolism in 25% of hospitalized COVID patients

Men and smokers were particularly prone to this condition, which, if left untreated, carries an up to 30% mortality rate.

Radiologists utilize novel CAD-RADS in 95% of coronary CTA reports

Massachusetts General Hospital doctors analyzed Coronary Artery Disease Reporting and Data System usage in their high-volume cardiac CT services center for the study.

New pulmonary embolism approach could substantially reduce imaging overuse

The pretest probability score produced false-negative rates below 1% and dropped imaging use by about 20%, according to a new JAMA Cardiology study.

Society of Cardiovascular Computed Tomography shares new CCTA guidance

The guidance, published in full in the Journal of Cardiovascular Computed Tomography, includes updates to previous CCTA recommendations and was designed to answer common questions.

Computed Tomography

Cardiologist Carlos Collet takes new leadership role with CRF

FDA clears GE Revolution Vibe CT scanner aimed at rapidly growing CCTA market

How to address CCTA staffing shortages

Nuclear imaging company Positron moves to New York for ‘exciting new chapter’

FDA clears CCTA AI coronary plaque assessment from Artrya